Axovant Sciences Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurological disorders. Axovant Sciences develops products to treat the cognitive impairment and behavioral disturbances associated with dementia.
[Note: the following has been revised based on updated voting results-- 9 March, 17:17 PM PST] Before the assembly election in El Salvador, I suggested that the FMLN should be expected to win 24.2% of the vote. I hedged, saying I thought the Salvadoran party system probably was still too rigid to allow one of its…
"Dear Colonel Lang, My architectural firm had a series of contracts to develop facility plans for 15 or so VA hospitals in the mid to late 90s. I was the Principal on them. Along with my team, I visited them,...
The Surgeon General says everyone should carry the antidote naloxone to fight opioid overdoses, but experts say words are not enough in this deadly epidemic.
Officials are close to limiting doses of the painkillers, but doctors say doing so could put older patients into withdrawal or lead them to buy deadly street drugs.
The people in prison are the ones who are dumb enough to get caught. The ones we miss are the most cunning.
President Trump hinted in a tweet on Sunday that the military could be tasked with building a wall on the Mexican border after a $1.3 trillion spending bill...
London park sees defiance, at least one man led away by police and concern that celebration of drug’s recreational use is at odds with strategy to end prohibition
Just say no to Trump’s opioid plan.
Supporters of the “right to try” bill said it would give dying patients a chance to obtain potentially helpful prescription drugs without waiting for the completion of clinical trials.
The Guardian journalist Deborah Orr began taking antidepressants this week – but only after a year of psychotherapy
Nurse Alex Wubbels said part of the $500,000 settlement will be used to help lead a campaign to stop physical and verbal abuse of nurses on the job.
Consumers can save thousands in out-of-pocket prescription costs. But there’s evidence they may only help Big Pharma’s bottom line.
As a junior doctor working in the intensive care unit (ICU) of a large American hospital, Daniela Lamas prided herself on not letting any of her patients die. Her job, she believed, was to keep hearts beating. Confronted with life-and-death scenarios, she hooked people up to machines and pumped them
The number of patients walking out of emergency departments without being formally discharged has reached record levels.More than 13,500 people abandoned their visit in December and January. The figures include 859 children whose parents thought they were sick enough to bring to hospital but left
Trump will announce his opioid plan in his visit to New Hampshire on Monday.
NYPD cops have been caught “testilying” on more than two dozen occasions since January 2015 — with some giving inaccurate accounts about witness...
Prosecutors say one owner of "sober homes" and a rehab facility billed insurers more than $58 million.
Medicare prescription drug coverage gap, aka the donut hole. People who get Extra Help paying Part D costs won't enter the coverage gap. Out of pocket costs help you get out of the coverage gap.
Jeff Sessions' opening salvo in his vendetta against marijuana has arrived. But state lawmakers, who will be responsible for enforcing the law, aren't happy.
Google's former SVP of People Operations Laszlo Bock breaks down how the tech giant remains at the front of the pack.